Barclays PLC Cronos Group Inc. Call Options Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 11, 2021	SELL	$5.0 - $8.85 $12,500 - $22,125	-2,500 Reduced 4.99%	47,600 $330,000
Q2 2020 Aug 12, 2020	SELL	$4.84 - $8.02 $1.92 Million - $3.17 Million	-395,800 Reduced 88.76%	50,100 $301,000
Q1 2020 May 13, 2020	BUY	$4.52 - $8.55 $158,199 - $299,250	35,000 Added 8.52%	445,900 $2.53 Million
Q4 2019 Feb 10, 2020	BUY	$6.14 - $9.3 $124,028 - $187,860	20,200 Added 5.17%	410,900 $3.15 Million
Q3 2019 Nov 14, 2019	SELL	$9.05 - $16.02 $2.63 Million - $4.66 Million	-290,800 Reduced 42.67%	390,700 $3.54 Million
Q2 2019 Aug 14, 2019	BUY	$13.58 - $18.61 $3.34 Million - $4.58 Million	246,300 Added 56.59%	681,500 $10.9 Million
Q1 2019 May 15, 2019	BUY	$11.31 - $23.7 $686,517 - $1.44 Million	60,700 Added 16.21%	435,200 $8.02 Million
Q4 2018 Feb 14, 2019	BUY	$6.8 - $12.88 $490,280 - $928,648	72,100 Added 23.84%	374,500 $3.89 Million
Q3 2018 Nov 14, 2018	BUY	$5.65 - $13.75 $1.71 Million - $4.16 Million	302,400 New	302,400 $3.36 Million

214

49.2M

4.58M

2.7M

Ticker CRON
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 377,896,000
Market Cap $820M
Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.